Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126457731 | 12645773 | 1 | I | 20160406 | 20160811 | 20160811 | PER | US-PFIZER INC-2016200789 | PFIZER | 78.00 | YR | F | Y | 45.30000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126457731 | 12645773 | 1 | PS | DIAZEPAM. | DIAZEPAM | 1 | 10MG EVERY 4 HOURS AS NEEDED | U | 71583 | 10 | MG | ||||||||
| 126457731 | 12645773 | 2 | SS | DIAZEPAM. | DIAZEPAM | 1 | UNK | U | 71583 | ||||||||||
| 126457731 | 12645773 | 3 | SS | DIAZEPAM. | DIAZEPAM | 1 | 5 MG, UNK | U | TEVA 3026 | 0 | 5 | MG | |||||||
| 126457731 | 12645773 | 4 | SS | DIAZEPAM. | DIAZEPAM | 1 | U | 0 | |||||||||||
| 126457731 | 12645773 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, UNK | 0 | 25 | MG | TABLET | |||||||
| 126457731 | 12645773 | 6 | C | AVAPRO | IRBESARTAN | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 126457731 | 12645773 | 7 | C | CLONIDINE HCL | CLONIDINE HYDROCHLORIDE | 1 | Oral | TABLETS 0.2MG, 1-3 TABS 3X A DAY | 0 | TABLET | TID | ||||||||
| 126457731 | 12645773 | 8 | C | GEMFIBROZIL. | GEMFIBROZIL | 1 | Oral | 600 MG, 2X/DAY | 0 | 600 | MG | BID | |||||||
| 126457731 | 12645773 | 9 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 300 MG, DAILY | 0 | 300 | MG | ||||||||
| 126457731 | 12645773 | 10 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 40 MG, DAILY | 0 | 40 | MG | ||||||||
| 126457731 | 12645773 | 11 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 75 UG, DAILY | 0 | 75 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126457731 | 12645773 | 1 | Anxiety |
| 126457731 | 12645773 | 3 | Hypertension |
| 126457731 | 12645773 | 4 | Anxiety |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126457731 | 12645773 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126457731 | 12645773 | Intentional product misuse | |
| 126457731 | 12645773 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126457731 | 12645773 | 1 | 2014 | 0 | ||
| 126457731 | 12645773 | 2 | 2015 | 0 | ||
| 126457731 | 12645773 | 3 | 2014 | 0 |